MGI Tech Co Ltd is a producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. It provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare, and other relevant industries.
2016
n/a
LTM Revenue $469M
LTM EBITDA -$17.7M
$4.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MGI Tech has a last 12-month revenue of $469M and a last 12-month EBITDA of -$17.7M.
In the most recent fiscal year, MGI Tech achieved revenue of $401M and an EBITDA of -$36.5M.
MGI Tech expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See MGI Tech valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $401M | $442M | XXX | XXX | XXX |
Gross Profit | $360M | $312M | XXX | XXX | XXX |
Gross Margin | 90% | 71% | XXX | XXX | XXX |
EBITDA | -$36.5M | -$41.2M | XXX | XXX | XXX |
EBITDA Margin | -9% | -9% | XXX | XXX | XXX |
Net Profit | $66.6M | $279M | XXX | XXX | XXX |
Net Margin | 17% | 63% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MGI Tech's stock price is CNY 79 (or $11).
MGI Tech has current market cap of CNY 33.1B (or $4.6B), and EV of CNY 30.1B (or $4.1B).
See MGI Tech trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$4.1B | $4.6B | XXX | XXX | XXX | XXX | $-0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MGI Tech has market cap of $4.6B and EV of $4.1B.
MGI Tech's trades at 8.8x LTM EV/Revenue multiple, and -234.1x LTM EBITDA.
Analysts estimate MGI Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MGI Tech and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $4.1B | XXX | XXX | XXX |
EV/Revenue | 9.4x | XXX | XXX | XXX |
EV/EBITDA | -100.5x | XXX | XXX | XXX |
P/E | -55.1x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 52.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMGI Tech's NTM/LTM revenue growth is 19%
MGI Tech's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, MGI Tech's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MGI Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MGI Tech and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 10% | XXX | XXX | XXX | XXX |
EBITDA Margin | -9% | XXX | XXX | XXX | XXX |
EBITDA Growth | 13% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 10% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 31% | XXX | XXX | XXX | XXX |
Opex to Revenue | 75% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MGI Tech acquired XXX companies to date.
Last acquisition by MGI Tech was XXXXXXXX, XXXXX XXXXX XXXXXX . MGI Tech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was MGI Tech founded? | MGI Tech was founded in 2016. |
Where is MGI Tech headquartered? | MGI Tech is headquartered in China. |
Is MGI Tech publicy listed? | Yes, MGI Tech is a public company listed on SHG. |
What is the stock symbol of MGI Tech? | MGI Tech trades under 688114 ticker. |
When did MGI Tech go public? | MGI Tech went public in 2022. |
Who are competitors of MGI Tech? | Similar companies to MGI Tech include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of MGI Tech? | MGI Tech's current market cap is $4.6B |
What is the current revenue of MGI Tech? | MGI Tech's last 12-month revenue is $469M. |
What is the current EBITDA of MGI Tech? | MGI Tech's last 12-month EBITDA is -$17.7M. |
What is the current EV/Revenue multiple of MGI Tech? | Current revenue multiple of MGI Tech is 8.8x. |
What is the current EV/EBITDA multiple of MGI Tech? | Current EBITDA multiple of MGI Tech is -234.1x. |
What is the current revenue growth of MGI Tech? | MGI Tech revenue growth between 2023 and 2024 was 10%. |
Is MGI Tech profitable? | Yes, MGI Tech is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.